Type 1 Diabetes

About 31% of a group of adults with type 1 diabetes prescribed a hybrid closed-loop insulin delivery system never initiated auto mode, and half of the never initiated group consisted of Black and Hispanic patients, according to study data.

Patients with type 1 diabetes presenting with symptoms of diabetic ketoacidosis may instead have ketosis due to cannabis hyperemesis syndrome, and several criteria can help avoid a misdiagnosis, according to data published in Diabetes Care.

Use of a hybrid closed-loop insulin-delivery system was associated with better glycemic control cor older adults with type 1 diabetes, according to a brief report published in Diabetes Technology & Therapeutics.

White Medicare beneficiaries were more likely to use an insulin pump or continuous glucose monitor than Black beneficiaries from 2017 to 2019, with the gap increasing over the 3-year period, according to study data.

Psychiatric conditions such as exposure to trauma, PTSD, depression, anxiety disorders and suicidal ideation are frequent among children with type 1 diabetes and may influence disease self-management, data show.

Fast-acting insulin aspart provides similar time in range as insulin aspart for adults with type 1 diabetes engaging in moderate- or high-intensity exercise, according to study findings published in Diabetes Technology & Therapeutics.

Glucose management indicator, a metric used with continuous glucose monitors, may be a better indicator of glycemic control during the first trimester of pregnancy than HbA1c, according to study findings.

Susan was diagnosed with type 1 diabetes half a century ago, at age 2 years. Management in the decades since has certainly changed, yet she has thrived.

A cohort of U.S. children with type 1 diabetes had a decrease in mean glucose level and glucose management indicator during the first year of the COVID-19 pandemic compared with the prior year, according to study data.

Children with type 1 diabetes who used an advanced hybrid closed-loop insulin delivery system for 1 year achieved an average time in range of 74%, surpassing clinical consensus guidelines, according to European data released by Medtronic.